2016, Number 2
<< Back Next >>
Rev Hematol Mex 2016; 17 (2)
The relation between drug companies and the physicians. Is it possible to have it healthy and clear?
Moraleda-Jiménez JM
Language: Spanish
References: 7
Page: 77-80
PDF size: 349.22 Kb.
Text Extraction
No abstract.
REFERENCES
Campbell EG, Gruen RL, Mountford J, Miller LG, et al. A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-1750.
Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429-433.
Campbell EG. Doctors and drug companies: scrutinizing influential relationships. N Engl J Med 2007;357:1796-1797.
Ruiz Argüelles GJ. A new breed in the teaching of medicine: paid lecturers, trainers or speakers? Acta Haematol 2016;135:191-192.
Gomez Córdoba AI, Latorre Santos C, Nel Carreño J. Dilemas éticos en las relaciones entre la industria farmacéutica y los profesionales de la salud. Persona y bioética 2007;11:23-38.
Ramchandren R, Schiffer CA, et al. ReCAP: pattern of duplicate presentations at national hemato-oncology meetings: influence of the pharmaceutical industry. J Oncol Pract 2016;12:252-253.
Código de Buenas Prácticas de la Industria Farmacéutica 2014. Disponible en: http://www.farmaindustria.es/idc/ groups/public/documents/publicaciones/FARMA_123819. pdf
Full text